Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01274507 · ClinicalTrials.gov registry record · Early Phase 1
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Early Phase 1 study, sponsored by Janssen Research & Development.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 328
- Enrollment target
NCT01274507: Completed Early Phase 1 study, sponsored by Janssen Research & Development.
NCT01274507 is a Early Phase 1 study that has completed, run by Janssen Research & Development. The registered enrollment target is 328 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (519% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01274507, a Early Phase 1 study, has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 328 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the clinical, physiologic, and molecular profiles of healthy participants, participants with mild, moderate, and severe asthma; and participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
Primary Outcome
AQLQ is used to measure the physical, emotional, social and occupational problems for participants with asthma. There are 32 questions in 4 domains (symptoms, activity limitation, emotional function and environmental stimuli) to measure activity limitation and symptom frequency using a recall period of 2 weeks. Each 32 questions are on a 7-point scale (7 = not impaired at all and 1 = severely impaired). The overall AQLQ score is the mean of all 32 responses and the individual domain scores are t
Interventions
- OTHER Medical tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-07 |
| Phase | Early Phase 1 |
What the finished NCT01274507 record still lists
NCT01274507 is an interventional study that assigns participants to a tested intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (519% higher).
The record links to 0 conditions, and to 1 intervention - of which Medical tests is the first listed.
NCT01274507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01274507 about?
NCT01274507 is a clinical study titled "A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease". The purpose of this study is to characterize the clinical, physiologic, and molecular profiles of healthy participants, participants with mild, moderate, and severe asthma; and participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
What is the current status of trial NCT01274507?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 328 participants. The study started on 2010-07. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01274507?
The interventions under investigation include: Medical tests (OTHER).
Who is sponsoring clinical trial NCT01274507?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01274507's enrollment target sits among peer trials
328 32nd of 2000 higher than 1,969 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
- NCT05548413 · 328 participants · NA
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
- NCT06393725 · 328 participants · NA
Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia